Sports supplements retailer MyProtein have fallen foul of the Advertising Standards Authority rules over “misleading” claims the firm were offering discounts of up to 60% on items during a monthly sale.
A majority of commercially available vitamin supplements in German market significantly exceed daily recommended doses recommended by the Federal Institute for Risk Assessment (BfR), new tests suggest.
The term ‘nutritious’ is regularly used in product marketing, but the way in which consumers and ‘experts’ view the word may be different, say researchers calling for an agreed definition.
Changes in South Africa’s legislation on vitamins and dietary supplements appear to be slowing growth in the market which has recently seen double digit growth, according to a recent Euromonitor podcast.
Manufacturers and distributors of very low calorie diet (VLCD) programmes and products could be effectively wiped out by new rules passed by European lawmakers last week, warn industry leaders.
The failure to register intellectual property (IP) rights on time is a common problem for foreign supplement and functional food companies in China, according to global co-head of CMS Life Sciences Sector Group Nick Beckett.
New ‘traditional use’ system could be source of new 13.1 claims
Simplification and centralisation of the European novel foods process means applications based on traditional use will soon be allowed – Resulting in shorter and cheaper routes to market, and the potential for using new fruits and juices that could come...
A press release highlighting a study that was presented at a recent meeting of the International Carotenoids Society has caused a deep rift between researchers and a prominent carotenoids supplier.
The European Food Safety Authority (EFSA) has delivered two new scientific opinions, rejecting applications Cargill and Loc Troi group for Article 13.5 and Article 14 health claims.
The European Food Safety Authority (EFSA) has said comments from Heinz questioning its refusal of an Article 14 health claim relating to Nutrimune late last year does not change its opinion.
Restrictions on word counts in scientific journals on the reporting of trials on the efficacy of supplements can hinder the quality of the reporting of the study, according to the author of a study which judged the quality of reporting to be “poor”.
